Adjuvant Serplulimab and Trastuzuma and Chemotherapy in Her-2+ Gastric Cancer

NCT05975749 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

114

Enrollment

OTHER

Sponsor class

Conditions

Gastric Cancer

Interventions

DRUG: Serplulimab
DRUG: Trastuzuma
DRUG: Chemotherapy

Sponsor

Fudan University